Dr. Kenneth R. Boren

Nephrology
4040 E Mclellan Rd Unit 11, 
Mesa, AZ 
4040 E Mclellan Rd Unit 11, 
Mesa, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kenneth Boren is a Nephrologist in Mesa, Arizona.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Nephrology
Licenses
Internal Medicine in AZ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE

Locations

4040 E Mclellan Rd Unit 11, Mesa, AZ 85205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-blind, Phase 3 Trial to Assess Clinical Efficacy, Safety and Reactogenicity of the Recombinant MVA-BN® -RSV Vaccine in Adults ≥60 Years of Age
A Randomized, Double-blind, Phase 3 Trial to Assess Clinical Efficacy, Safety and Reactogenicity of the Recombinant MVA-BN® -RSV Vaccine in Adults ≥60 Years of Age
Enrollment Status: Terminated
Publish Date: October 31, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
Randomized, Multicenter, Double-blind, Parallel-Group, Placebo & Comparator-Controlled Study to Compare the Glycemic Effects, Safety & Tolerability of Metformin Delayed-Release Tablets in Patients With Type 2 Diabetes Mellitus
Randomized, Multicenter, Double-blind, Parallel-Group, Placebo & Comparator-Controlled Study to Compare the Glycemic Effects, Safety & Tolerability of Metformin Delayed-Release Tablets in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Suspended
Publish Date: March 14, 2023
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 3
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
Enrollment Status: Completed
Publish Date: March 31, 2022
Intervention Type: Drug
Study Drug: DM199
Study Phase: Phase 2
View 6 Less Clinical Trials
Similar Doctors
Expertise in
6
conditions
Dr. Raymond L. Heilman
Nephrology
Expertise in
6
conditions
Dr. Raymond L. Heilman
Nephrology

Mayo Clinic Arizona

13400 E Shea Blvd, 
Scottsdale, AZ 
 (11.4 miles away)
480-301-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Raymond Heilman is a Nephrologist in Scottsdale, Arizona. Dr. Heilman is highly rated in 6 conditions, according to our data. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Necrosis, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Heilman is currently accepting new patients.

Expertise in
36
conditions
Dr. Mashood Qadri
Nephrology
Expertise in
36
conditions
Dr. Mashood Qadri
Nephrology

Desert Kidney Associates Plc

612 W Baseline Rd, 
Mesa, AZ 
 (8.2 miles away)
480-834-9039
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Mashood Qadri is a Nephrologist in Mesa, Arizona. Dr. Qadri is highly rated in 36 conditions, according to our data. His top areas of expertise are Acute Kidney Failure, Renovascular Hypertension, Nephrosclerosis, and Necrosis. Dr. Qadri is currently accepting new patients.

Expertise in
31
conditions
Dr. Rajesh M. Kumar
Nephrology
Expertise in
31
conditions
Dr. Rajesh M. Kumar
Nephrology

Desert Kidney Associates Plc

612 W Baseline Rd, 
Mesa, AZ 
 (8.2 miles away)
480-834-9039
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajesh Kumar is a Nephrologist in Mesa, Arizona. Dr. Kumar is highly rated in 31 conditions, according to our data. His top areas of expertise are Acute Kidney Failure, Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Percutaneous Coronary Intervention (PCI). Dr. Kumar is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Boren's expertise for a condition
ConditionClose

We do not have enough information to identify the Areas of Expertise for this provider.

Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile